New Genomics Lab in Liberia Monitors Genetic Changes in the Deadly Ebola Virus

US Army Medical Research Institute of Infectious Diseases (USAMRIID) researchers have established the first genomic surveillance capability in Liberia, enabling them to monitor genetic changes in the Ebola virus within one week of sample collection.

Until now, efforts to sequence the genome of Ebola virus, Makona, have been hampered by the time it took to send samples back to the United States for analysis, according to Jeffrey Kugelman, USAMRIID.

United Nations Experts Denounce WHO's Slow Response to Ebola Outbreak in West Africa
The UN panel claims it's unclear why early warnings of the Ebola crisis, approximately from May through to July 2014, did not result in an effective response.

The Makona strain was responsible for the current Ebola outbreak in West Africa.

"It just was not happening fast enough," Kugelman said. "We need answers in days, rather than in weeks or months," Kugelman added.

Kugelman recently returned from Liberia, where he spent four months setting up the genomics laboratory at the Liberian Institute for Biomedical Research (LIBR).

Latest Data on Ebola Virus Rules Out Rapid Accumulation of Deadlier Mutations
The Ebola virus evolved as it spread to new areas but it did not change at a faster rate than it has in past outbreaks in the west across Sierra Leone.

The laboratory, a collaborative effort between LIBR and USAMRIID, was established to characterize Ebola viral genomes to assess the erosion of diagnostic and therapeutic targets, as well as to provide the scientific and public health communities working in Liberia with viral genomic information.

According to the authors, evaluating changes in the virus in real time was essential to determine whether those changes could have an impact on diagnostics and therapeutics.

Italian Male Nurse Working With an NGO in Sierra Leone Tested Positive for Ebola
The Italian nurse who contracted the ebola virus will be transferred to the capital's Lazzaro Spallanzani hospital, which specializes in infectious diseases.

"It is a fully functional genomics lab--and the fact that we have been able to put next-generation sequencing into the outbreak area has made quite an impact," Kugelman said.

The details were published online in the journal Emerging Infectious Diseases.

Kenya Lifts Travel Ban from Liberia After It was Declared Ebola-Free by WHO
However, Doctors Without Borders has urged the government to be cautious until the disease is completely extinguished in neighboring Guinea and Sierra Leone.

Source-IANS